Novo Nordisk has a commercial relationship with Economist Impact, a division of The Economist Group. The Economist operates ...

The Government has joined forces with the pharmaceutical giant that makes weight loss jab Mounjaro in a bid to tackle obesity ...

A recent study aimed to assess evidence on the safety and complications of preoperative glucagon-like peptide-1 (GLP-1) ...

Eating excessive calories is 10 times more influential than sedentariness in driving the obesity epidemic, researchers say.

As the fourth high level meeting of the United Nations General Assembly on non-communicable diseases (NCDs) approaches, Bai Li and colleagues warn that failing to tackle obesity will set back progress ...

Overweight patients waiting for operations could safely use a particular type of weight-loss treatment to reduce the risk of ...

The Government and pharmaceutical giant Eli Lilly, the creator of weight loss drug Mounjaro, are teaming up to explore and ...

Healthy SA Healthy SA: Tackling the obesity epidemic through clinical trials You could get a free weight-loss drug if you qualify for clinical trials run by Flourish Research. 00:00 00:00 ...

Glucagon-like peptide 1 receptor agonists, including semaglutide, have increased in use and will continue to increase due to their effectiveness in weight loss.

VERU unveils a novel modified-release oral enobosarm to enhance fat loss while preserving lean mass in chronic weight loss management.

Prime Minister Narendra Modi, during his 79th Independence Day speech on August 15, 2025, issued a strong warning about India’s accelerating obesity epidemic. He urged all families to reduce cooking ...

A new report illustrates in stark terms how the obesity epidemic in the US has spiraled in the past two decades and pinpoints, on a state-by-state basis, where the largest increases have occurred ...